✨Juice✨

High volume up day for $sava again. Shorts have no shares to borrow still. The shorts are very offsides here because they have ignored to positive clinical data while obsessing on 15 year old western blot images. These blot idiots don’t understand the 95% of the science outside of blots that confirms the drug works. They are also ignoring the positive clinical trial data. It’s simply not normal for a drug to keep an Alzheimer’s patient cognition stable for 24 months. It was reported across dozens of clinical trial sites.